4//SEC Filing
Litchman Manuel MD 4
Accession 0001104659-24-068409
CIK 0001680048other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 8:33 PM ET
Size
7.0 KB
Accession
0001104659-24-068409
Insider Transaction Report
Form 4
Litchman Manuel MD
DirectorPresident, CEO and Interim CFO
Transactions
- Tax Payment
Common Stock
2022-04-24$12.15/sh−1,248$15,163→ 80,992 total - Tax Payment
Common Stock
2023-04-24$4.21/sh−1,572$6,618→ 79,420 total
Footnotes (4)
- [F1]1,248 shares of common stock were relinquished to cover tax liability associated with the delivery of shares of common stock upon the vesting of restricted stock units.
- [F2]The amount of common stock reflected on this Form 4 has been adjusted to reflect a 1-for-15 reverse stock split that occurred subsequent to this transaction.
- [F3]1,572 shares of common stock were relinquished to cover tax liability associated with the delivery of shares of common stock upon the vesting of restricted stock units.
- [F4]Includes 3,975 shares of common stock acquired under the Mustang Bio, Inc. Employee Stock Purchase Plan on March 1, 2023 and September 1, 2023.
Documents
Issuer
MUSTANG BIO, INC.
CIK 0001680048
Entity typeother
Related Parties
1- filerCIK 0001709485
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 8:33 PM ET
- Size
- 7.0 KB